SKYVaricella (a live attenuated varicella vaccine) safety issues revisited
Joowon Lee · 2026
Read SKYVaricella (a live attenuated varicella vaccine) safety issues revisited by Joowon Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13473981.txt.
Description
Joowon Lee revisits safety questions in 2026 for a chickenpox vaccine made in Korea and sold as SKYVaricella. The vaccine uses a weakened live virus and won national approval in 2018, then global prequalification a year later. After a child died from spread of the vaccine virus, Korean agencies reviewed the case in 2024. They cleared the vaccine of causing the death and kept it in the national program.
The review notes a higher rate of shingles seen in children who got this vaccine. The maker updated its risk plan in 2024 to list shingles as a key possible risk. Lee argues that detailed follow-up steps have yet to be shared in public. Parents and doctors gain a clear record of what is known and what remains open.
Catalog record
| CREATOR | Joowon Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10553 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |